Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies


Summary

Bone cement and casting materials are used to fix bone fractures or as a complement to other devices in procedures such as joint reconstruction and trauma fixation. GlobalData's Medical Devices sector report, “Orthopedic Bone Cement and Casting Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Orthopedic Bone Cement and Casting Materials pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Orthopedic Bone Cement and Casting Materials report provides key information and data related to:

Extensive coverage of the Orthopedic Bone Cement and Casting Materials under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Orthopedic Bone Cement and Casting Materials pipeline products.

Review of Recent Developments in the segment / industry

The Orthopedic Bone Cement and Casting Materials report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Orthopedic Bone Cement and Casting Materials under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
  • 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
  • 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
  • 64,000+ medical equipment company profiles
  • 5,600+ company profiles of medical equipment manufacturers in China and India
  • 2,200+ company profiles of medical equipment manufacturers in Japan
  • 1,200+ companies’ revenue splits and market shares
  • 1,600+ quarterly and annual medical equipment company financials
  • 850+ medical equipment company SWOTs
  • 28,000+ pipeline product profiles
  • 56,400+ marketed product profiles
  • 47,000+ clinical trials
  • 41,500+ trial investigators
  • 7,000+ reports on companies with products in development
  • 44,000+ deals in the medical equipment industry
  • 1,100+ surgical and diagnostic procedures by therapy area
  • 50+ key healthcare indicators by country
  • 431,000+ Themes Content Items
  • 600+ Influencers
  • 1,900+ Analysts & Researchers
  • 0.5m+ Community Members
  • 141,000+ Macroeconomic Indicators
  • 1,013,000+ City Indicators
Scope
  • Extensive coverage of the Orthopedic Bone Cement and Casting Materials under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Orthopedic Bone Cement and Casting Materials and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Orthopedic Bone Cement and Casting Materials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • Orthopedic Bone Cement and Casting Materials Overview
  • Products under Development
    • Orthopedic Bone Cement and Casting Materials - Pipeline Products by Stage of Development
      • Table Figure 1: Orthopedic Bone Cement and Casting Materials - Pipeline Products by Stage of Development
      • Table Orthopedic Bone Cement and Casting Materials - Pipeline Products by Stage of Development
    • Orthopedic Bone Cement and Casting Materials - Pipeline Products by Segment
      • Table Figure 2: Orthopedic Bone Cement and Casting Materials - Pipeline Products by Segment Pipeline Products by Segment
      • Table Orthopedic Bone Cement and Casting Materials - Pipeline Products by Segment
    • Orthopedic Bone Cement and Casting Materials - Pipeline Products by Territory
      • Table Figure 3: Orthopedic Bone Cement and Casting Materials - Pipeline Products by Territory
      • Table Orthopedic Bone Cement and Casting Materials - Pipeline Products by Territory
    • Orthopedic Bone Cement and Casting Materials - Pipeline Products by Regulatory Path
      • Table Figure 4: Orthopedic Bone Cement and Casting Materials - Pipeline Products by Regulatory Path
      • Table Orthopedic Bone Cement and Casting Materials - Pipeline Products by Regulatory Path
    • Orthopedic Bone Cement and Casting Materials - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Orthopedic Bone Cement and Casting Materials - Pipeline Products by Estimated Approval Date
      • Table Orthopedic Bone Cement and Casting Materials - Pipeline Products by Estimated Approval Date
    • Orthopedic Bone Cement and Casting Materials - Ongoing Clinical Trials
      • Table Figure 6: Orthopedic Bone Cement and Casting Materials - Ongoing Clinical Trials
      • Table Orthopedic Bone Cement and Casting Materials - Ongoing Clinical Trials
  • Orthopedic Bone Cement and Casting Materials - Pipeline Products under Development by Companies
    • Orthopedic Bone Cement and Casting Materials Companies - Pipeline Products by Stage of Development
      • Table Orthopedic Bone Cement and Casting Materials Companies - Pipeline Products by Stage of Development
    • Orthopedic Bone Cement and Casting Materials - Companies Pipeline Products by Stage of Development
      • Table Orthopedic Bone Cement and Casting Materials - Companies Pipeline Products by Stage of Development
  • Orthopedic Bone Cement and Casting Materials Companies and Product Overview
    • Biofix Medical Technologies Company Overview
      • Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Glass Ionomer Cement - Product Status
        • Table Injectable Glass Ionomer Cement - Product Description
    • Bone-Rad Therapeutics, Inc. Company Overview
      • Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spine-Rad Brachytherapy Bone Cement - Product Status
        • Table Spine-Rad Brachytherapy Bone Cement - Product Description
    • Chinese Academy of Sciences Company Overview
      • Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table BG Bone Cement - Product Status
        • Table BG Bone Cement - Product Description
    • Dalhousie University Company Overview
      • Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Minimally Invasive System - Bone Augmentation - Product Status
        • Table Minimally Invasive System - Bone Augmentation - Product Description
    • DePuy Synthes Inc Company Overview
      • DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Statin Eluting Bone Cements - Product Status
        • Table Statin Eluting Bone Cements - Product Description
    • Exactech Inc Company Overview
      • Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cemex Bone Cement - Product Status
        • Table Cemex Bone Cement - Product Description
    • Graftys SA Company Overview
      • Graftys SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Graftys SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table GRFT-M03 - Product Status
        • Table GRFT-M03 - Product Description
        • Table GRFT-M05 - Product Status
        • Table GRFT-M05 - Product Description
    • Hyalex Orthopaedics Inc Company Overview
      • Hyalex Orthopaedics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hyalex Orthopaedics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hyalex Bone Cement - Product Status
        • Table Hyalex Bone Cement - Product Description
    • Inossia AB Company Overview
      • Inossia AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inossia AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table V-Flex - Product Status
        • Table V-Flex - Product Description
        • Table Inossia AB - Ongoing Clinical Trials Overview
        • Table V-Flex - A Multicentre, Single-blind, RCT to Document the Safety and Efficacy of the Use of a Bone Cement With or Without Inossia Cement Softener for Patients With Vertebral Compression Fractures
    • Maxigen Biotech Inc Company Overview
      • Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MaxCement - Product Status
        • Table MaxCement - Product Description
    • Medical Compression Systems (DBN) Ltd Company Overview
      • Medical Compression Systems (DBN) Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medical Compression Systems (DBN) Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ActiveCast - Product Status
        • Table ActiveCast - Product Description
    • MediPrint Company Overview
      • MediPrint Pipeline Products & Ongoing Clinical Trials Overview
        • Table MediPrint Pipeline Products & Ongoing Clinical Trials Overview
        • Table NovaCast - Product Status
        • Table NovaCast - Product Description
    • Moroxite F AB Company Overview
      • Moroxite F AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Moroxite F AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fracture Fixation Device - Product Status
        • Table Fracture Fixation Device - Product Description
        • Table Moroxite F AB - Ongoing Clinical Trials Overview
        • Table Fracture Fixation Device - An Open-labelled Pilot Study to Evaluate Dynamic Hip Screw System (DHS) Augmented With a Biphasic Apatite Sulphate Combined With Systemic or Local Bisphosphonate for Trochanteric Femur Fracture
    • National University of Science and Technology MiSiS Company Overview
      • National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview
        • Table National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ceramic Composite Polymer - Product Status
        • Table Ceramic Composite Polymer - Product Description
    • Next Casting Technologies Company Overview
      • Next Casting Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Casting Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation SmartCast - Product Status
        • Table Next Generation SmartCast - Product Description
    • Onbone Oy Company Overview
      • Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview
        • Table Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview
        • Table BIOCEMENT - Product Status
        • Table BIOCEMENT - Product Description
    • OSARTIS GmbH Company Overview
      • OSARTIS GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table OSARTIS GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ag Cement - Product Status
        • Table Ag Cement - Product Description
    • Osseon Therapeutics Inc Company Overview
      • Osseon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Osseon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Monetite - Based Injectable Orthopaedic Cement - Product Status
        • Table Monetite - Based Injectable Orthopaedic Cement - Product Description
    • Ozics AG Company Overview
      • Ozics AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ozics AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table CompO6 Reinforced Bone Composite - Osteoporotic Fractures - Product Status
        • Table CompO6 Reinforced Bone Composite - Osteoporotic Fractures - Product Description
    • Queen Mary University of London Company Overview
      • Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Calcium Phosphate Bone Cement - Product Status(Queen Mary University of London)
        • Table Calcium Phosphate Bone Cement - Product Description(Queen Mary University of London)
    • Queen's University Belfast Company Overview
      • Queen's University Belfast Pipeline Products & Ongoing Clinical Trials Overview
        • Table Queen's University Belfast Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spinal Cement - Product Status
        • Table Spinal Cement - Product Description
    • Setbone Medical Ltd Company Overview
      • Setbone Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Setbone Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ReadySet Bone Cement - Product Status
        • Table ReadySet Bone Cement - Product Description
    • Shenzhen Healthemes Biotechnology Co Ltd Company Overview
      • Shenzhen Healthemes Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shenzhen Healthemes Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shenzhen Bone Cement - Product Status
        • Table Shenzhen Bone Cement - Product Description
        • Table Shenzhen Healthemes Biotechnology Co Ltd - Ongoing Clinical Trials Overview
        • Table Shenzhen Bone Cement - Clinical Trial for the Safety and Effectiveness of Bone Cement in Filling and Stabilizing Vertebral Body
        • Table Shenzhen Bone Cement - Clinical Trial for the Safety and Effectiveness of Bone Cement in Filling and Stabilizing Vertebral Body - Dec 2023
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
      • Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials
        • Table Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioCaS - Product Status
        • Table BioCaS - Product Description
        • Table Bone Cement - Product Status
        • Table Bone Cement - Product Description
        • Table Calcium Phosphate Bone Cement - Product Status
        • Table Calcium Phosphate Bone Cement - Product Description
    • Stryker Corp Company Overview
      • Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cortoss - Cranial Defects - Product Status
        • Table Cortoss - Cranial Defects - Product Description
    • University of Limerick Company Overview
      • University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioactive Adhesive Cement - Product Status
        • Table Bioactive Adhesive Cement - Product Description
        • Table Dual Calcium Phosphate Paste System - Product Status
        • Table Dual Calcium Phosphate Paste System - Product Description
        • Table Heracap - Product Status
        • Table Heracap - Product Description
    • University of Missouri Company Overview
      • University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bone Cement - Product Status(University of Missouri)
        • Table Bone Cement - Product Description(University of Missouri)
    • Zimmer Biomet Holdings Inc Company Overview
      • Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cobalt Stage One Acrylic Spacer Cement - Product Status
        • Table Cobalt Stage One Acrylic Spacer Cement - Product Description
    • Zimmer GmbH Company Overview
      • Zimmer GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Zimmer GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Resurgent - Product Status
        • Table Resurgent - Product Description
  • Orthopedic Bone Cement and Casting Materials- Recent Developments
    • Oct 30, 2023: Japan Medical Dynamic Marketing Announces Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 2024
    • Oct 23, 2023: Jan Gurander Proposed as New Chairman of Essity
    • Oct 09, 2023: Stryker to Host Investor Day
    • Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
    • Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023
    • Sep 25, 2023: OrthoPediatrics was a Gold Level Sponsor of the Scoliosis Research Society 58th Annual Meeting
    • Sep 14, 2023: Smith & Nephew Brings BT Chief Financial Officer Simon Lowth to Board
    • Sep 14, 2023: New Non Executive Directors Join the Board at Med Tech Business
    • Sep 14, 2023: Smith & Nephew Announces Board Changes
    • Sep 05, 2023: Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team
    • Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
    • Aug 22, 2023: Zimmer Biomet Announces Leadership Transition
    • Aug 10, 2023: Essity Hires Sandra Aberg as Vice President and Head of Investor Relations
    • Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
    • Jul 28, 2023: Japan Medical Dynamic Marketing Announces Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 2024
    • Jun 13, 2023: AAP Implantate Executive Board proposes in the invitation to the Annual General Meeting various capital measures for resolution
    • May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
    • May 02, 2023: Zimmer Biomet Publishes 2022 Sustainability Report
    • Apr 28, 2023: Japan Medical Dynamic Marketing announces summary of consolidated financial results for the fiscal year ended March 2023
    • Apr 27, 2023: Essity releases interim report for Q1 2023
    • Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update
    • Apr 12, 2023: Medtronic has a layoff in California
    • Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report
    • Mar 31, 2023: OrthoPediatrics Leading Sponsorship at Annual EPOS Meeting
    • Mar 28, 2023: Stryker announces Annual Meeting of Shareholders
    • Mar 22, 2023: Vitrolife Notice to attend the Annual General Meeting
    • Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
    • Mar 10, 2023: Ossur Announces Results of the Annual General Meeting
    • Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022
    • Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting
    • Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results
    • Feb 17, 2023: Ossur Announces Annual General Meeting
    • Jan 31, 2023: Ossur Announces Annual Report 2022
    • Jan 31, 2023: Ossur Announces Interim Report Q4 & FY 2022
    • Jan 31, 2023: Japan Medical Dynamic Marketing Announces Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 2023
    • Jan 17, 2023: Ossur Announces Conference Call Tuesday 31 January at 9:00 CET
    • Jan 09, 2023: ATEC Announces Select Preliminary Financial 2022 Results, 2023 Guidance and Closing of Flexible, Non-Dilutive Debt Facility
    • Dec 12, 2022: Change to Essity's Executive Management Team
    • Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings